Bearish: Analysts Just Cut Their Nanya Technology Corporation (TWSE:2408) Revenue and EPS estimates

Market forces rained on the parade of Nanya Technology Corporation (TWSE:2408) shareholders today, when the analysts downgraded their forecasts for this year. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting the analysts have soured majorly on the business.

After the downgrade, the consensus from Nanya Technology's eight analysts is for revenues of NT$32b in 2025, which would reflect a noticeable 6.1% decline in sales compared to the last year of performance. Losses are expected to increase substantially, hitting NT$1.90 per share. Before this latest update, the analysts had been forecasting revenues of NT$47b and earnings per share (EPS) of NT$2.07 in 2025. So we can see that the consensus has become notably more bearish on Nanya Technology's outlook with these numbers, making a sizeable cut to this year's revenue estimates. Furthermore, they expect the business to be loss-making this year, compared to their previous forecasts of a profit.

Check out our latest analysis for Nanya Technology

earnings-and-revenue-growth
TWSE:2408 Earnings and Revenue Growth January 15th 2025

The consensus price target fell 19% to NT$41.30, implicitly signalling that lower earnings per share are a leading indicator for Nanya Technology's valuation.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Nanya Technology's past performance and to peers in the same industry. We would also point out that the forecast 6.1% annualised revenue decline to the end of 2025 is better than the historical trend, which saw revenues shrink 13% annually over the past five years Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to grow 18% annually. So it's pretty clear that, while it does have declining revenues, the analysts also expect Nanya Technology to suffer worse than the wider industry.

Advertisement

The Bottom Line

The most important thing to take away is that analysts are expecting Nanya Technology to become unprofitable this year. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Nanya Technology's revenues are expected to grow slower than the wider market. With a serious cut to this year's expectations and a falling price target, we wouldn't be surprised if investors were becoming wary of Nanya Technology.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Nanya Technology analysts - going out to 2026, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

Valuation is complex, but we're here to simplify it.

Discover if Nanya Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TWSE:2408

Nanya Technology

Research, develops, manufactures, and sells semiconductor products in Taiwan, Japan, Malaysia, China, the United States, Thailand, Germany, Singapore, Poland and internationally.

Exceptional growth potential with adequate balance sheet.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0775.1% undervalued
112 users have followed this narrative
1 users have commented on this narrative
20 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9823.0% undervalued
35 users have followed this narrative
0 users have commented on this narrative
30 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1559.0% undervalued
15 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3653.2% undervalued
12 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

CO
composite32
FRU logo
composite32 on Freehold Royalties ·

Freehold: Offers a fantastic growth-income intersection up to $50 WTI. Below $50 WTI, it may offer historic opportunities in terms of ROI.

Fair Value:CA$19.813.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
ADBE logo
Vestra on Adobe ·

Adobe (ADBE): Record Q1 AI-Revenue and the End of the Shantanu Narayen Era

Fair Value:US$572.452.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
MDXH logo
Vestra on MDxHealth ·

MDxHealth (MDXH): Liquid Biopsy Hypergrowth and the Strategic Path to 10% EBITDA Margins

Fair Value:US$7.556.7% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.378.3% undervalued
53 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.6% undervalued
1306 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.6% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative